Elizabeth C. de Boer

Induction of urinary interleukin-1 (IL-1), IL-2, IL-6, and tumour necrosis factor during intravesical immunotherapy with bacillus Calmette-Guérin in superficial bladder cancer

Elizabeth C. de Boer, Wim H. de Jong, P. A. Steerenberg et al. · Cancer Immunology Immunotherapy · 1992 · 198 citations · Full text

Tumour Necrosis Factor, Urology, Cancer Immunosurveillance +7

Urinary Cytokines During Intravesical Bacillus Calmetteguerin Therapy for Superficial Bladder Cancer: Processing, Stability and Prognostic Value

Theo M. de Reijke, Elizabeth C. de Boer, Karl H. Kurth et al. · The Journal of Urology · 1996 · 181 citations

Presence of activated lymphocytes in the urine of patients with superficial bladder cancer after intravesical immunotherapy with bacillus Calmette-Guérin

Elizabeth C. de Boer, Wim H. de Jong, A.P.M. van der Meijden et al. · Cancer Immunology Immunotherapy · 1991 · 111 citations · Full text

Urological Research, Urology, Genitourinary Cancer +8

Leukocytes in the urine after intravesical BCG treatment for superficial bladder cancer

Elizabeth C. de Boer, Wim H. de Jong, A.P.M. van der Meijden et al. · Urological Research · 1991 · 100 citations

Urological Research, Urology, Genitourinary Cancer +7

Role of interleukin-8 in onset of the immune response in intravesical BCG therapy for superficial bladder cancer

Elizabeth C. de Boer, László Somogyi, G. J. W. De Ruiter et al. · Urological Research · 1997 · 74 citations

Urology, Cancer Immunosurveillance, Genitourinary Cancer +9